Adhering to the DASH diet during pregnancy significantly reduces the risk of having large-for-gestational-age (LGA) newborns, a key factor in preventing future metabolic disorders. This study highlights the role of healthy dietary patterns in improving maternal and fetal health outcomes.
After an $80M Series D raise, DalCor takes another shot at a PhIII myocardial infarction trial
DalCor Pharmaceuticals has regrouped from past setbacks to complete an $80 million Series D round to advance its cholesteryl ester transfer protein (CETP) inhibitor, dalcetrapib,